Quest Diagnostics (DGX) Shares Repurchased (2009 - 2025)

Quest Diagnostics has disclosed Shares Repurchased across 17 years of filings, most recently posting $300.0 million for Q4 2025.

• Shares Repurchased for Q4 2025 came in at $300.0 million, up 98.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $726.0 million (up 70.42% YoY), and the FY2025 annual result was $450.0 million, up 198.01% from the prior year.
• Shares Repurchased came in at $300.0 million for Q4 2025 at Quest Diagnostics, up from $151.0 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $1.5 billion in Q2 2021 to a low of $151.0 million in Q4 2024.
• The 5-year median for Shares Repurchased is $336.5 million (2022), against an average of $433.3 million.
• Across the five-year window, Shares Repurchased soared 446.67% in 2021 and plunged 86.67% in 2022, its largest moves.
• Quest Diagnostics' Shares Repurchased stood at $289.0 million in 2021, then soared by 59.52% to $461.0 million in 2022, then tumbled by 40.35% to $275.0 million in 2023, then sank by 45.09% to $151.0 million in 2024, then jumped by 98.68% to $300.0 million in 2025.
• The last three Shares Repurchased figures came in at $300.0 million (Q4 2025), $151.0 million (Q4 2024), and $275.0 million (Q4 2023), per Business Quant data.